166 related articles for article (PubMed ID: 33565773)
21. Laboratory errors leading to nonmelanoma skin cancer recurrence after Mohs micrographic surgery.
Zabielinski M; Leithauser L; Godsey T; Gloster HM
Dermatol Surg; 2015 Aug; 41(8):913-6. PubMed ID: 26218725
[TBL] [Abstract][Full Text] [Related]
22. Surgical margins in the treatment of nonmelanoma skin cancer and mohs micrographic surgery.
Lane JE; Kent DE
Curr Surg; 2005; 62(5):518-26. PubMed ID: 16125611
[TBL] [Abstract][Full Text] [Related]
23. Innovative 19-minute rapid cytokeratin immunostaining of nonmelanoma skin cancer in Mohs micrographic surgery.
Cherpelis BS; Turner L; Ladd S; Glass LF; Fenske NA
Dermatol Surg; 2009 Jul; 35(7):1050-6. PubMed ID: 19469800
[TBL] [Abstract][Full Text] [Related]
24. Clinical application of dynamic telepathology in Mohs surgery.
Sukal SA; Busam KJ; Nehal KS
Dermatol Surg; 2005 Dec; 31(12):1700-3. PubMed ID: 16336890
[TBL] [Abstract][Full Text] [Related]
25. Dermoscopy to identify biopsy sites before Mohs surgery.
Jawed SI; Goldberg LH; Wang SQ
Dermatol Surg; 2014 Mar; 40(3):334-7. PubMed ID: 24447179
[No Abstract] [Full Text] [Related]
26. Concordance between a Mohs surgeon and a dermatopathologist in evaluating Mohs cryosections.
Atilla S; Gököz Ö; Özer S; Elçin G
J Eur Acad Dermatol Venereol; 2021 Nov; 35(11):2219-2224. PubMed ID: 34331818
[TBL] [Abstract][Full Text] [Related]
27. The importance of reviewing pathology specimens before Mohs surgery.
Butler ST; Youker SR; Mandrell J; Flanagan KH; Fosko SW
Dermatol Surg; 2009 Mar; 35(3):407-12. PubMed ID: 19175663
[TBL] [Abstract][Full Text] [Related]
28. Bioimpedance measurement as an assessment of margin positivity in Mohs surgical specimens of nonmelanoma skin cancer: Management implications.
Svoboda RM; Gharia MJ; Shell J; Gregory WD
J Am Acad Dermatol; 2018 Sep; 79(3):591-593. PubMed ID: 29544743
[No Abstract] [Full Text] [Related]
29. Patient-reported health outcomes in patients with non-melanoma skin cancer and actinic keratosis: results from a large-scale observational study analysing effects of diagnoses and disease progression.
Philipp-Dormston WG; Müller K; Novak B; Strömer K; Termeer C; Hammann U; Glutsch JW; Krähn-Senftleben G; Lübbert H; Koller M; Szeimies RM;
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1138-1146. PubMed ID: 29150868
[TBL] [Abstract][Full Text] [Related]
30. Defining recurrence of nonmelanoma skin cancer after Mohs micrographic surgery: Report of the American College of Mohs Surgery Registry and Outcomes Committee.
Leitenberger JJ; Rogers H; Chapman JC; Maher IA; Fox MC; Harmon CB; Bailey EC; Odland P; Wysong A; Johnson T; Wisco OJ
J Am Acad Dermatol; 2016 Nov; 75(5):1022-1031. PubMed ID: 27546292
[TBL] [Abstract][Full Text] [Related]
31. Pitfalls in frozen section interpretation in Mohs micrographic surgery.
Hitchcock MG; Leshin B; White WL
Adv Dermatol; 1997; 13():427-62. PubMed ID: 9551151
[No Abstract] [Full Text] [Related]
32. Nonmelanoma skin cancer of the head and neck: surgical treatment.
Akcam TM; Gubisch W; Unlu H
Facial Plast Surg Clin North Am; 2012 Nov; 20(4):455-71. PubMed ID: 23084298
[TBL] [Abstract][Full Text] [Related]
33. How accurate is frozen section for skin cancers?
Manstein ME; Manstein CH; Smith R
Ann Plast Surg; 2003 Jun; 50(6):607-9. PubMed ID: 12783011
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical techniques in Mohs micrographic surgery: their potential use in the detection of neoplastic cells masked by inflammation.
Jimenez FJ; Grichnik JM; Buchanan MD; Clark RE
J Am Acad Dermatol; 1995 Jan; 32(1):89-94. PubMed ID: 7529778
[TBL] [Abstract][Full Text] [Related]
35. The Skin Cancer Index: quality-of-life outcomes of treatments for nonmelanoma skin cancer.
Sanchez N; Griggs J; Nanda S; Fayne R; Castillo D; De Bedout V; Meirson D; Nichols A
J Dermatolog Treat; 2020 Aug; 31(5):491-493. PubMed ID: 31566077
[No Abstract] [Full Text] [Related]
36. Micrographic surgery of malignant skin tumors: a comparison of the frozen technique with paraffin sectioning.
Breuninger H
Facial Plast Surg; 1997 Apr; 13(2):79-82. PubMed ID: 9243982
[No Abstract] [Full Text] [Related]
37. Validation of Whole Slide Imaging for Intraoperative Consultation During Mohs Micrographic Surgery.
Harrell J; Nielson C; Konda S; Motaparthi K
Dermatol Surg; 2021 May; 47(5):703-705. PubMed ID: 33259167
[No Abstract] [Full Text] [Related]
38. Pink lesions.
Giacomel J; Zalaudek I
Dermatol Clin; 2013 Oct; 31(4):649-78, ix. PubMed ID: 24075552
[TBL] [Abstract][Full Text] [Related]
39. Risk of synchronous and metachronous second nonmelanoma skin cancer when referred for Mohs micrographic surgery.
Schinstine M; Goldman GD
J Am Acad Dermatol; 2001 Mar; 44(3):497-9. PubMed ID: 11209121
[TBL] [Abstract][Full Text] [Related]
40. A deep learning algorithm to detect the presence of basal cell carcinoma on Mohs micrographic surgery frozen sections.
Sohn GK; Sohn JH; Yeh J; Chen Y; Brian Jiang SI
J Am Acad Dermatol; 2021 May; 84(5):1437-1438. PubMed ID: 32590033
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
